These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7439926)

  • 1. Modified hybridoma methodology: antigen-directed chemically mediated cell fusion.
    Kranz DM; Billing PA; Herron JN; Voss EW
    Immunol Commun; 1980; 9(7):639-51. PubMed ID: 7439926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody production by hybridomas.
    Goding JW
    J Immunol Methods; 1980; 39(4):285-308. PubMed ID: 7007515
    [No Abstract]   [Full Text] [Related]  

  • 3. Analysis of human monoclonal antibodies derived from lymphocytes of patients with cancer.
    Cote RJ; Morrissey DM; Oettgen HF; Old LJ
    Fed Proc; 1984 Jun; 43(9):2465-9. PubMed ID: 6327400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of hybrids of mouse myeloma cells and protozoa which express parasite antigens.
    Rodriguez-Lopez MH; Crocker PR; Harrison TJ; Targett GA; Bradley DJ
    Immunology; 1984 Aug; 52(4):727-32. PubMed ID: 6378772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of cell surface and intracellular antigens by human monoclonal antibodies. Hybrid cell lines derived from lymphocytes of patients with malignant melanoma.
    Houghton AN; Brooks H; Cote RJ; Taormina MC; Oettgen HF; Old LJ
    J Exp Med; 1983 Jul; 158(1):53-65. PubMed ID: 6864164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved fusion technique. II. Stability and purity of hybrid clones.
    Westerwoudt RJ; Naipal AM; Harrisson CM
    J Immunol Methods; 1984 Mar; 68(1-2):89-101. PubMed ID: 6538588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of the number of monoclonal hybridomas in a cell fusion experiment. Effect of post-fusion cell dilution on hybridoma survival.
    De Blas AL; Ratnaparkhi MV; Mosimann JE
    J Immunol Methods; 1981; 45(2):109-15. PubMed ID: 7288193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and characterization of a murine hybridoma secreting monoclonal anti-DNA autoantibody.
    Tron F; Charron D; Bach JF; Talal N
    J Immunol; 1980 Dec; 125(6):2805-9. PubMed ID: 7191869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase of hybridoma formation by human lymphocytes after stimulation in vitro; effect of antigen, endothelial cells, and PWM.
    Astaldi GC; Wright EP; Willems C; Zeijlemaker WP; Janssen MC
    J Immunol; 1982 Jun; 128(6):2539-42. PubMed ID: 6804563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of hybridomas secreting monoclonal antibodies against components of normal and malignant cells.
    Eshhar Z; Hurwitz E; Hadas E
    Prog Clin Biol Res; 1980; 47():357-65. PubMed ID: 7193867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen-promoted cell fusion: antigen-coated myeloma cell fuse with antigen-reactive spleen cells.
    Bankert RB; DesSoye D; Powers L
    Transplant Proc; 1980 Sep; 12(3):443-6. PubMed ID: 6164138
    [No Abstract]   [Full Text] [Related]  

  • 12. Monoclonal antibody-recognizing tumor-associated antigen of DBA/2 mouse lymphoma L1210 and its sublines.
    Fuji H
    Transplant Proc; 1980 Sep; 12(3):388-90. PubMed ID: 6784299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased frequency of both total and specific monoclonal antibody producing hybridomas using a fusion partner that constitutively expresses recombinant IL-6.
    Harris JF; Hawley RG; Hawley TS; Crawford-Sharpe GC
    J Immunol Methods; 1992 Apr; 148(1-2):199-207. PubMed ID: 1373425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of heteromyeloma fusion partners which promote the outgrowth of porcine hybridomas.
    Greenlee AR; Magnuson NS; Smith C; Butt BM; McKiernan AJ; Davis WC
    Vet Immunol Immunopathol; 1990 Nov; 26(3):267-83. PubMed ID: 2264287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybridomas secreting monoclonal antibody with specificity for Toxoplasma gondii.
    Sethi KK; Endo T; Brandis H
    J Parasitol; 1980 Apr; 66(2):192-6. PubMed ID: 7391860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antistreptococcal group A antibodies: production after in vitro activation and hybridization of mouse spleen cells.
    Herbst H; Braun DG
    Ann Immunol (Paris); 1981; 132C(1):87-100. PubMed ID: 7020569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colcemid treatment of myeloma prior to cell fusion increases the yield of hybridomas between myeloma and splenocyte.
    Miyahara M; Nakamura H; Hamaguchi Y
    Biochem Biophys Res Commun; 1984 Nov; 124(3):903-8. PubMed ID: 6508785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to major histocompatibility antigens produced by hybrid cell lines.
    Galfre G; Howe SC; Milstein C; Butcher GW; Howard JC
    Nature; 1977 Apr; 266(5602):550-2. PubMed ID: 558524
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of mouse hybridomas by fusion of myeloma cells with lymphocytes derived from spleen, lymph node, and bone marrow.
    Başalp A; Yücel F
    Hybrid Hybridomics; 2003 Oct; 22(5):329-31. PubMed ID: 14678651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal competition and stability of hybrid myelomas of mouse and rat origin.
    Galfré G; Butcher GW; Howard JC; Wide CD; Milstein C
    Transplant Proc; 1980 Sep; 12(3):371-5. PubMed ID: 6784297
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.